Trial Profile
A Phase II/III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Cethrin in Subjects With Acute Cervical Spinal Cord Injury
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II/III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Praconase (Primary)
- Indications Spinal cord injuries
- Focus Therapeutic Use
- Sponsors BioAxone Biosciences
- 25 Nov 2014 Status changed from not yet recruiting to withdrawn prior to enrolment, according to ClinicalTrials.gov record.
- 24 Sep 2014 New trial record